IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: American Tower Corporation
Symbol: AMT
Price: Last trade $97.33
Trade Date: 2/26
Shares: 23.5 million
Underwriter(s) Goldman Sachs, BofA Merrill Lynch, Barclays, Citigroup, J.P. Morgan
Rating=Subscription Needed
Company: Relypsa, Inc.
Symbol: RLYP
Price: Last trade $38.27
Trade Date: 2/26
Shares: 3.4 million
Underwriter(s) BofA Merrill Lynch, Cowen & Co.
Co Manager(s) Oppenheimer, Stifel, Wedbush PacGrow Life Sciences
Rating=Subscription Needed
Company: Celldex
Symbol: CLDX
Price: Last trade $25.48
Trade Date: 2/26
Shares: 7.25 million
Underwriter(s) Jefferies & Co., Leerink Swann, Guggenheim Securities
Rating=Subscription Needed
Company: Curis, Inc.
Symbol: CRIS
Price: Last trade $2.80
Trade Date: 2/25
Shares: 17.8 million
Underwriter(s) Cowen & Co., RBC Capital Markets
Rating=Subscription Needed
Company: Tandem Diabetes Care, Inc.
Symbol: TNDM
Price: Last trade $13.10
Trade Date: 2/27
Shares: 4.6 million
Underwriter(s) BofA Merrill Lynch, Piper Jaffray
Co Manager(s) Deutsche Bank Securities, Stifel
Rating=Subscription Needed
Company: AMAG Pharmaceuticals
Symbol: AMAG
Price: Last trade $44.18
Trade Date: 2/26
Shares: 2.83 million
Underwriter(s) J.P. Morgan, Deutsche Bank Securities
Rating=Subscription Needed
Company: Armstrong World Industries, Inc.-BLOCK
Symbol: AWI
Price: Last trade $55.64
Trade Date: 2/25
Shares: 2.9 million
Underwriter(s) Morgan Stanley
Rating=Subscription Needed
Company: Macquarie Infrastructure
Symbol: MIC
Price: Last trade $79.81
Trade Date: 2/26
Shares: 4.4 million
Underwriter(s) Barclays Capital, Macquarie Capital, J.P. Morgan, RBC Capital Markets, SunTrust Robinson Humphrey
Rating=Subscription Needed